The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Education & TrainingFull Access

Course Goals

Published Online:https://doi.org/10.1176/pn.37.9.0020a

APA’s new online course, “Buprenorphine for Office-Based Treatment of Opioid-Dependent Patients,” will prepare psychiatrists to treat patients addicted to opiates with buprenorphine in an office-based setting. By the end of the course, psychiatrists should

• have a greater understanding of office-based treatment with buprenorphine,

• be able to identify the clinically relevant pharmacological characteristics of buprenorphine,

• be able to determine whether the patient is an appropriate candidate for office-based treatment with buprenorphine,

• understand the treatment of patients with medical comorbidity,

• be able to develop a plan for treatment with buprenorphine,

• have a greater understanding of current laws protecting patients’ confidentiality, and

• be able to incorporate the principles taught in the buprenorphine course into clinical practice.